Drug intelligence / Profile preview

hydrogen-oxygen mixed gas

Development stage
Unknown
Lead developer
Asclepius Meditec
Administration
Inhalation
01

Overview

Hydrogen-oxygen mixed gas is a medical inhalation therapy consisting of a gaseous mixture of molecular hydrogen (H₂) and molecular oxygen (O₂), typically in a 2:1 ratio (66% H₂ and 33% O₂), generated by the electrolysis of water. The mixture is delivered noninvasively via nasal cannula or nebulizer devices directly to the respiratory tract. The primary mechanism involves both improved oxygen delivery due to lower density and direct biological effects from molecular hydrogen. Hydrogen acts as an antioxidant by scavenging hydroxyl radicals and peroxynitrite ions, reduces inflammation through modulation of proinflammatory cytokines, and may have cytoprotective effects on lung tissue. This therapy has been studied primarily for respiratory diseases such as COVID-19 pneumonia, asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, tracheal stenosis, and has also shown potential benefits in hypertension-related organ damage. Clinical studies suggest that it can alleviate dyspnea and hypoxemia without significant side effects[1][2][3][7][8][9]. It is officially recommended in China for COVID-19 treatment.

Brand names
AMS-H-01AMS-H01AMS-H 01AMS-H-03AMS-H03AMS-H 03
Other names
oxy-hydrogen gashydrogen/oxygen mixed gashydrogen oxygen therapy

Beyond the preview

Go deeper on hydrogen-oxygen mixed gas.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrogen-oxygen mixed gas.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call